期刊文献+

血栓前体蛋白对血栓形成性疾病的诊断价值 被引量:3

Diagnostic Value of TpP in Vascular Thrombotic Diseases
下载PDF
导出
摘要 【目的】探讨血浆中血栓前体蛋白(TpP)的检测对急性心肌梗死(AMI)、急性脑梗死(ACI)、不稳定心绞痛(UA)、弥漫性血管内凝血(DIC)的临床诊断意义。【方法】利用酶联免疫方法(ELISA)定量测定50例健康对照者、33例AMI患者发病6 h前后、28例UA、18例ACI治疗前后、17例DIC各期血浆中TpP的浓度。【结果】AMI患者发病6 h内、ACI治疗前后、DIC各期血浆TpP水平与健康对照组相比较有显著性差异(P<0.01),AMI发病6h后及UA与健康对照组相比差异无显著性(P>0.05);AMI患者发病6 h前后比较、ACI患者治疗前和治疗后7 d比较有显著性差异(P<0.01);DIC患者消耗性低凝期、纤溶亢进期与高凝期、治疗后期比较均有显著性差异(P<0.01)。【结论】TpP对血栓形成性疾病的诊断有一定的价值,可作为AMI、ACI、DIC的早期诊断指标,并且对ACI和DIC的病程发展、疗效评估有较积极的意义。 [Objective]To discuss the clinical value of plasma thrombus precursor protein (TpP) in the di agnosis of acute myocardial infarction (AMI) acute cerebrovascular infarction (ACI); unstable angina (UA) and disseminated intravascular coagulation (DIC) . [Methods]The concentrations of TpP in 50 healthy people, 33 patients with AMI before or after falling ill in 6 hours,28 patients with UA,18 patients with ACI before or after treatment and 17 patients with DIC were measured by enzyme linked immunosorbent assay (ELISA). [Results]There were significant differences in patients with AMI failing ill in 6 hours, patients with ACI before or after treatment, patients with DIC during the four periods compared with the healthy people. There was no significant difference in the patients with AMI 6 hours after falling ill and patients with UA compared with the healthy people. There were significant differences in patients with AMI before falling ill compared with af ter falling ill in 6 hours, patients with ACI before treatment compared with after treatment in 7 days. [Conclusion]There is diagnosis value of TpP in thrombosis diseases, it can be the earlier diagnostic index of AMI, ACI and DIC, provide more referable positive value for the treatment and prognosis of ACI and DIC.
出处 《医学临床研究》 CAS 2006年第9期1401-1403,共3页 Journal of Clinical Research
关键词 血栓形成/诊断 蛋白质前体 thrombosis/DI protein precursors
  • 相关文献

参考文献7

  • 1Carville N.An immunological assay for the determination of circulating levels of thrombus precursor protein[J].Clinical Hemosta sis Review,1997,27 (1):65-67.
  • 2Francis CW,Conagham DG,Scott WL,et al.Increased plasma concentrations of corss-linked fibrin polymers in acute myocardial infarction[J].Circulation,1987,75(6):1170-1176.
  • 3Francis CW,Kormberg A.Fibrinogen and fibrin degradation products during fibrinolytic therapy[J].Annals of the New York Academy of Sciences,1993,667,310-323.
  • 4David GM.Carville thrombus precursor protein (TpP):marker of thrombosis early in the pathogenesis of myocardial infarction[J].Clinical Chemistry,1956,429:1537-1541.
  • 5Laurino JP,Pelletier TE,Eadry R,et al.Thrombus precursor protein and the measurement of thrombosis in patents with acute chest pain syndrome[J].Ann Clin Lab Sci,1997,27 (5):338-345.
  • 6郑美琴,杨军军,陈慧,徐晓杰.DIC病人血浆中血栓前体蛋白的测定[J].血栓与止血学,2003,9(3):118-119. 被引量:5
  • 7邱丽君,周琪,顾青,沈立松.深静脉血栓形成与止血调节临床检验试验的关系[J].上海交通大学学报(医学版),2006,26(1):78-80. 被引量:3

二级参考文献8

  • 1[1]Carville N.An immunological assay for the determination of circulating levels of thrombus precursor protein.Clinical Hemostasis Review,1997,27:65.
  • 2[4]Song KS,Kim HK,Song JW.Measurement of thrombus precursor protein in septic patients with disseminated intravascular coagulation and liver disease.Haematologica,2002,87(10):1062~1067
  • 3[5]Arkel YS,Paidas MJ,Ku DH.The use of coagulation activiation markers in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.Blood Coagul Fibrinolysis,2002,13(3):199~205.
  • 4[1]Kahn SR.The clinical diagnosis of deep venous thrombosis,integrating incidence,risk factors and symptoms and signs[J].Arch Intern Med,1998,158(21):2315-2323.
  • 5[5]O'Donnell J,Mumford AD,Manning RA,et al.Marked elevation of thrombin generation in patients with elevated FⅧ:C and venous thromboembolism[J].Br J Haematol,2001,115(3):687-691.
  • 6[6]Aarker LA,Mann KG.Thrombosis and fibrinolysis[M]//Fuster V,Verstraete M,eds.Thrombosis in cardiovascular disorders.Philadephia:WB Saunders,1992:1-16.
  • 7[7]Tajanko E,Galar M,Piszcz J,et al.Diagnostic value of hemostasis activation markers in acute deep vein thrombosis[J].Pol Arch Med Wewn,2002,107(3):237-241.
  • 8[8]LaCapra S,Arkel YS,Ku DH,et al.The use of thrombus precursor protein,D-dimer,prothrombin fragment1+2,and thrombin antithromibin in the exclusion of proximal deep vein thrombosis and pulmonary embolism[J].Blood Coagul Fibrinolysis,2000,11(4):371-377.

共引文献6

同被引文献29

  • 1李卓江,吴嘉.凝血酶原片段F1+2、凝血酶原时间比率与口服抗凝治疗[J].临床血液学杂志,1996,9(2):71-73. 被引量:8
  • 2俞燕,吴翔.血栓前体蛋白对不稳定型心绞痛患者预后判断及相关因素的研究[J].陕西医学杂志,2006,35(4):397-399. 被引量:3
  • 3徐辉,蔡凯,李介华,夏明凯,黄超龙,张小勇,李嘉维.血栓前体蛋白和高敏C反应蛋白在心房颤动患者中含量变化及其临床意义[J].广东医学,2006,27(4):555-556. 被引量:3
  • 4Bokarev IN, Nemchinov EN, Ermolaeva OA. Thrombus precursor protein(soluble monomeric protein) in patients with acute coronary syndrome. Kiln Med(Mosk), 2006,84: 27-30.
  • 5Mega JL, Morrow DA, de Lemos J A, et al. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes. J Am Coil Cardiol,2008,51:2422-2429.
  • 6Ota S,Wada H,Nobori T,et al. Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer. Am J Hematol, 2005,79:274-280.
  • 7Kozlova TV. The prognostic value of thrombus precursor protein in the assessment of the probability for venous thrombosis recurrence after the completion of anticoagulatory therapy with warfarin. Klin Med(Mosk), 2006,84: 51-53.
  • 8Hinterhuber G, Bohler K, Kittler H, et al. Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia. Dermatol Surg, 2006,32 : 632-639.
  • 9Mega JL,Morrow DA,de Lemos JA,et al.Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.J Am Coll Cardiol,2008,51:2422-2429.
  • 10Hinterhuber G,Bohler K,Kittler H,et al.Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia.Dermatol Surg,2006,32:632-639.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部